Experience

FDA Advertising/Promotion

Presented to senior executives and other management of a start-up pharmaceutical company on complying with U.S. Department of Food and Drug Administration (FDA) advertising and promotion requirements pre- and post-launch.

On-Site Counsel

Served as on-site, long-term legal counsel for various pharmaceutical and device companies during times of staffing shortage at the companies.

Informed Consent Form Templates

Developed 23 different types of global research informed consent templates for a major pharmaceutical company along with detailed negotiation guidelines for compliance with applicable laws and best practices.

European Union GDPR—Pharmaceutical Company

Advised pharmaceutical company on all aspects of compliance with the European Union General Data Protection Regulation (GDPR), including gap analysis, policy and procedure development, and vendor and other third party contract revisions.

CAN-SPAM/E-Sign Act

Acted as the go-to advisor for a pharmaceutical company for advice on CAN-SPAM and E-Sign Act.

International Clinical Trials

Advised various pharmaceutical companies on the implementation of international clinical trials and related U.S. and ex-U.S. legal issues, including under FDA regulations, Health Insurance Portability and Accountability Act of 1996 (HIPAA), the GDPR, and foreign research and privacy laws.

Firm Highlights

Publication/Podcast

Corporate Transparency Act—Considerations Affecting Entities That Are Exempt or Excluded from Reporting Company Status

The Corporate Transparency Act ( CTA ) takes effect starting January 1, 2024. The Act is administered by FinCEN , a bureau of U.S. Treasury charged with combatting money laundering and other financial crimes...

Blog

Use of Retirement Plan Forfeitures: The IRS Proposed Regulations, Recent Litigation, and the DOL’s Position

In five recently filed class action lawsuits, [1] 401(k) plan participants allege that plan fiduciaries violated ERISA by using plan forfeitures to offset employer contributions instead of paying plan expenses. The use of forfeitures...

Event

Annual Employment Law Update

More details coming soon!

Matter

Elections and Constitutional Law: Successfully Challenged Certification of Initiative Petition

In a victory for consumers and the ride-hailing public, the Massachusetts Supreme Judicial Court recently barred the Secretary of State from placing on the November ballot initiative petitions proposed by companies such as Uber...

News

Expanded 2024 Maine Diversity Summer Associate Program Now Accepting Applications

Publication/Podcast

Determining Whether Your Entity is a Reporting Company: Selected Issues

Under the Corporate Transparency Act ( CTA ), more than 30 million “ Reporting Companies ” will need to register with FinCEN (a bureau of U.S. Treasury Department) and file Beneficial Ownership Information...

Blog

HIPAA Privacy Rule Changes: Just in time for the New Year?

In 2021, the Department of Health and Human Services (HHS) proposed changes to the Privacy Rule under the Health Insurance Portability and Accessibility Act of 1996 (HIPAA) that would significantly alter the current regulations...

Blog

Maine PUC Amends Small Generator Interconnection Procedures Rules (Chapter 324)

On November 3, 2023, the Maine Public Utilities Commission (the “Commission”) issued an Order adopting amendments to its Small Generator Interconnection Procedures Rule (Chapter 324). Background. Chapter 324 was last amended on December 21...

News

Verrill Recognized Nationally for Health Care, Land Use and Zoning, Commercial Litigation, Real Estate, and Trust & Estates by Best Lawyers®

Matter

Successful Representation of Insurer before U.S. District Court for the District of Maine

Verrill successfully represented an insurer before the U.S. District Court for the District of Maine in an insurance coverage matter alleging that the insurer improperly denied a defense and indemnification to a landlord under...

Contact Verrill at (855) 307 0700